🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Study to Observe the Long-term Safety of Odevixibat in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment

Recruitingn/aAges 6 Months - anyAllIpsen
NCT07585097 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study will collect information from patients with ALGS who are using odevixibat in their daily lives. Odevixibat is a medication that helps patients with ALGS, a rare disease that affects the liver and causes itching. The main aim of this study is to observe the long-term, everyday safety of the drug odevixibat in patients with ALGS who are receiving ongoing treatment.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Diagnosed with ALGS. * On (or starting) active odevixibat treatment. * Aged 6 months or older at the time of consent. Exclusion Criteria: * Currently participating in a clinical trial with odevixibat. * Currently participating in any interventional clinical trial for ALGS. * Have any contraindication to odevixibat as per the locally approved label.
💊

What it tests

  • Not listed
📍

Where

14 sites
Hospices Civils de Lyon - Hopital Femme Mere Enfant
Bron, France
CHU Dijon Bourgogne
Dijon, France
APHP - Hopital Bicetre - Paris Sud
Le Kremlin-Bicêtre, France
APHM - CHU Timone
Marseille, France
CHU de Montpellier - Hopital Saint Eloi
Montpellier, France
APHP - Hopital Necker-Enfants Malades
Paris, France
CHU de Toulouse - Hopital Paule de Viguier
Toulouse, France
APHP - Centre Hepato-Biliaire Hospital Paul Brousse
Villejuif, France

…and 6 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy